Celltrion Healthcare, a Korean biopharmaceutical company has made a significant investment in bio-similar products and achieved a breakthrough with its most up-to-date technology in bio science. With its currently sole product, Remsima and upcoming pipelines for other biosimilar products and new biologics, we are showing a sky-rocketing increases in sales as of 2014 worldwide and still growing with an aim to become the one of the leading pharmaceutical companies in the world.Celltrion has established the Celltrion Global Safety Data Center Inc. in the Philippines as a separate local corporation, and we want to hire great talents to work for us.
Celltrion Healthcare, a Korean biopharmaceutical company has made a significant investment in bio-similar products and achieved a breakthrough with its most up-to-date technology in bio science. With its currently sole product, Remsima and upcoming pipelines for other biosimilar products and new biologics, we are showing a sky-rocketing increases in sales as of 2014 worldwide and still growing with an aim to become the one of the leading pharmaceutical companies in the world.Celltrion has established the Celltrion Global Safety Data Center Inc. in the Philippines as a separate local corporation, and we want to hire great talents to work for us.
Celltrion Healthcare, a Korean biopharmaceutical company has made a significant investment in bio-similar products and achieved a breakthrough with its most up-to-date technology in bio science. With its currently sole product, Remsima and upcoming pipelines for other biosimilar products and new biologics, we are showing a sky-rocketing increases in sales as of 2014 worldwide and still growing with an aim to become the one of the leading pharmaceutical companies in the world.Celltrion has established the Celltrion Global Safety Data Center Inc. in the Philippines as a separate local corporation, and we want to hire great talents to work for us.